Statin cost effectiveness in primary prevention: A systematic review of the recent cost-effectiveness literature in the United States

被引:33
|
作者
Aaron P Mitchell
Ross J Simpson
机构
[1] Medical Residency Office Rm 8254DN,Duke University Medical Center
[2] UNC-Chapel Hill School of Medicine,Department of Cardiology
关键词
Statin; Cost-effectiveness; Primary prevention; Drug cost; Systematic review;
D O I
10.1186/1756-0500-5-373
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Cost-Effectiveness of Hormone Therapy in the United States
    Lekander, Ingrid
    Borgstrom, Fredrik
    Strom, Oskar
    Zethraeus, Niklas
    Kanis, John A.
    JOURNAL OF WOMENS HEALTH, 2009, 18 (10) : 1669 - 1677
  • [42] COST-EFFECTIVENESS OF TICLOPIDINE IN PRIMARY STROKE PREVENTION
    HUSE, DM
    LACEY, MJ
    OSTER, G
    EPSTEIN, AM
    CLINICAL RESEARCH, 1990, 38 (02): : A257 - A257
  • [43] Cost-effectiveness of ColoSTAT for primary colorectal cancer screening in the United States
    He, Emily
    Deak, Elena
    Schmitt, Laetitia Helene Marie
    Alesso, Sonia Maria
    Gilbert, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Cost-effectiveness of the treatment and prevention of osteoporosis—a review of the literature and a reference model
    N. Zethraeus
    F. Borgström
    O. Ström
    J. A. Kanis
    B. Jönsson
    Osteoporosis International, 2007, 18 : 9 - 23
  • [45] PSYCHOLOGISTS IN DISEASE PREVENTION AND HEALTH PROMOTION - A REVIEW OF THE COST-EFFECTIVENESS LITERATURE
    GROTHMARNAT, G
    SCHUMAKER, J
    PSYCHOLOGY, 1995, 32 (01): : 1 - 10
  • [46] Cost-effectiveness of the treatment and prevention of osteoporosis -: a review of the literature and a reference model
    Zethraeus, N.
    Borgstrom, F.
    Strom, O.
    Kanis, J. A.
    Jonsson, B.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 (01) : 9 - 23
  • [47] Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes
    Li, Te
    Wan, Xu
    Ma, Jin
    Wu, Bin
    ADVANCES IN THERAPY, 2018, 35 (12) : 2214 - 2223
  • [48] Cost-effectiveness analysis for statin therapies in the primary prevention of coronary heart disease in Italy
    Berto, P
    Munro, V
    Gaddi, A
    Negrini, C
    Hutton, J
    Mast, O
    CLINICAL DRUG INVESTIGATION, 2000, 20 (02) : 109 - 121
  • [49] Cost-Effectiveness Analysis for Statin Therapies in the Primary Prevention of Coronary Heart Disease in Italy
    Patrizia Berto
    Vicky Munro
    Antonio Gaddi
    Cristina Negrini
    John Hutton
    Oliver Mast
    Clinical Drug Investigation, 2000, 20 : 109 - 121
  • [50] Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis
    Greving, J. P.
    Visseren, F. L. J.
    de Wit, G. A.
    Algra, A.
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 342